Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Turning Point Therapeutics, Inc. TPTX
$75.49
На 18:01, 12 мая 2023
-2.50%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
0.00000000
-
week52high
-
week52low
-
Revenue
30829000
-
P/E TTM
-14
-
Beta
-0.19406400
-
EPS
-5.57300000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 авг 2022 г. в 04:00
Описание компании
Turning Point Therapeutics, Inc., a clinical-stage precision oncology biopharmaceutical company, engages in designing and developing therapies that target genetic drivers of cancer. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-naïve and TKI-pretreated patients. The company's lead drug candidate repotrectinib is being evaluated in an ongoing Phase 1/2 trial called TRIDENT-1 for the treatment of patients with ROS1+ advanced non-small-cell lung cancer (NSCLC) and patients with ROS1+ and NTRK+ advanced solid tumors. It also develops TPX-0022, a MET/SRC/CSF1R inhibitor, which is in Phase 1 SHIELD-1 clinical trial for patients with advanced solid tumors harboring genetic alterations in MET; TPX-0046, a RET inhibitor that is in 1/2 SWORD-1 clinical trial for patients with advanced solid tumors harboring RET genetic alterations; and TPX-0131, an ALK inhibitor, which is in Phase 1/2 FORGE-1 study for patient with advanced or metastatic TKI-pretreated ALK-positive NSCLC. Turning Point Therapeutics, Inc. was founded in 2013 and is headquartered in San Diego, California. As of August 15, 2022, Turning Point Therapeutics, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
SVB Leerink | Market Perform | Outperform | 13 июн 2022 г. |
HC Wainwright & Co. | Neutral | Buy | 06 июн 2022 г. |
Cowen & Co. | Market Perform | Outperform | 06 июн 2022 г. |
Wedbush | Neutral | Outperform | 03 июн 2022 г. |
Goldman Sachs | Buy | Buy | 24 мая 2022 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Nicholson Garry A | D | 0 | 8500 | 17 авг 2022 г. |
George Simeon | D | 0 | 8500 | 17 авг 2022 г. |
George Simeon | D | 0 | 8500 | 17 авг 2022 г. |
Machado Patrick | D | 0 | 8500 | 17 авг 2022 г. |
Bodem Barbara W. | D | 0 | 14995 | 17 авг 2022 г. |
Gallagher Carol Giltner | D | 0 | 30000 | 17 авг 2022 г. |
Alles Mark J | D | 0 | 209 | 17 авг 2022 г. |
Alles Mark J | D | 0 | 209 | 17 авг 2022 г. |
TOMBESI PAOLO | D | 0 | 58600 | 17 авг 2022 г. |
TOMBESI PAOLO | D | 0 | 58600 | 17 авг 2022 г. |
Свежие комментарии
Свежие комментарии